M E Hellard
Overview
Explore the profile of M E Hellard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen C, Dawe J, Traeger M, Sacks-Davis R, Pedrana A, Doyle J, et al.
Int J Drug Policy
. 2024 Sep;
133:104562.
PMID: 39299141
Background: Reversing declining rates of people initiating and completing hepatitis C (HCV) treatment, observed in many countries, is needed to achieve global HCV elimination goals. Providing financial incentives to increase...
2.
Schroeder S, Bourne A, Doyle J, Hellard M, Stoove M, Pedrana A
Int J Drug Policy
. 2022 Aug;
108:103808.
PMID: 35914477
Background: Gay and bisexual men (GBM) have higher substance use prevalences than general population samples - often attributed to stigmatisation of sexual minority identities. We examined how influential public health...
3.
Wade A, Doyle J, Gane E, Stedman C, Draper B, Iser D, et al.
Trials
. 2018 Jul;
19(1):383.
PMID: 30012192
Background: To achieve the World Health Organization hepatitis C virus (HCV) elimination targets, it is essential to increase access to treatment. Direct-acting antiviral (DAA) treatment can be provided in primary...
4.
Wade A, McCormack A, Roder C, McDonald K, Davies M, Scott N, et al.
J Viral Hepat
. 2018 Apr;
25(9):1089-1098.
PMID: 29660212
To increase access to treatment, the Australian government enabled general practitioners (GPs) to prescribe direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV)-in consultation with a specialist if inexperienced in...
5.
Ampt F, El Hayek C, Agius P, Bowring A, Bartnik N, VAN Gemert C, et al.
Epidemiol Infect
. 2017 May;
145(12):2530-2535.
PMID: 28528588
Identification of priority populations such as men who have sex with men (MSM) is important in surveillance systems to monitor trends of sexually transmitted infections (STIs). We explored using routinely...
6.
Winter R, Young J, Stoove M, Agius P, Hellard M, Kinner S
Drug Alcohol Depend
. 2016 Sep;
168:104-111.
PMID: 27635997
Introduction: Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of...
7.
Winter R, Stoove M, Degenhardt L, Hellard M, Spelman T, Jenkinson R, et al.
Drug Alcohol Depend
. 2015 Jun;
153:43-9.
PMID: 26105708
Introduction: Release from prison is a period of elevated risk for drug-related harms, particularly among people who inject drugs (PWID). Non-fatal overdose can cause serious morbidity and predicts future fatal...
8.
Doyle J, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, et al.
J Viral Hepat
. 2015 Jun;
22(12):1020-32.
PMID: 26098993
Pegylated interferon therapy is highly effective in recently acquired HCV. The optimal timing of treatment, regimen and influence of host factors remains unclear. We aimed to measure sustained virological response...
9.
Aspinall E, Weir A, Sacks-Davis R, Spelman T, Grebely J, Higgs P, et al.
Int J Drug Policy
. 2013 Dec;
25(1):179-82.
PMID: 24315504
Background: People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk...
10.
Gold J, Aitken C, Dixon H, Lim M, Gouillou M, Spelman T, et al.
Health Educ Res
. 2011 Mar;
26(5):782-94.
PMID: 21447750
Mobile phone text messages (SMS) are a promising method of health promotion, but a simple and low cost way to obtain phone numbers is required to reach a wide population....